Suzuken Co Ltd
TSE:9987
EV/GP
Enterprise Value to Gross Profit
Market Cap | EV/GP | ||||
---|---|---|---|---|---|
JP |
Suzuken Co Ltd
TSE:9987
|
355.1B JPY | 0.6 | ||
US |
Mckesson Corp
NYSE:MCK
|
68B USD | 5.8 | ||
US |
Cencora Inc
NYSE:COR
|
47.3B USD | 5.3 | ||
US |
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 4.4 | ||
US |
Cardinal Health Inc
NYSE:CAH
|
25.9B USD | 3.4 | ||
US |
Henry Schein Inc
NASDAQ:HSIC
|
9B USD | 2.9 | ||
KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 19.4 | |
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
62B HKD | 0.8 | ||
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
55.1B CNY | 4.3 | ||
IT |
Amplifon SpA
MIL:AMP
|
7.1B EUR | 5.4 | ||
CN |
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
50.7B CNY | 2.3 |
EV/GP Forward Multiples
Forward EV/GP multiple is a version of the EV/GP ratio that uses forecasted gross profit for the EV/GP calculation. 1-Year, 2-Years, and 3-Years forwards use gross profit forecasts for 1, 2, and 3 years ahead, respectively.